ConductScience.org, home

Paper29434873

Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer.

Zhang J and 4 others. Oncol Lett, 2018. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer. Papers, record 29434873. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29434873

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer.
PubMed
Journal
Oncol Lett
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.61
iCite
Revised in PubMed
2020-10-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang JJianbo
2Liu CChengxin
3Mo XXinkai
4Shi HHuan
5Li SSheng

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117903729Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.J Am Coll Surg2007https://conductscience.org/library/papers/17903729PubMed
224998559Study on the relationship between CXCR4 expression and perineural invasion in pancreatic cancer.Asian Pac J Cancer Prev2014https://conductscience.org/library/papers/24998559PubMed
326356032CXCR4 in breast cancer: oncogenic role and therapeutic targeting.Drug Des Devel Ther2015https://conductscience.org/library/papers/26356032PubMed
425287686The intricate role of CXCR4 in cancer.Adv Cancer Res2014https://conductscience.org/library/papers/25287686PubMed
524840182Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4.Cancer Biol Ther2014https://conductscience.org/library/papers/24840182PubMed
615164986CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells.J Neurooncol2004https://conductscience.org/library/papers/15164986PubMed
711929756Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1.Blood2002https://conductscience.org/library/papers/11929756PubMed
812388552CXCR4 is a major chemokine receptor on glioma cells and mediates their survival.J Biol Chem2002https://conductscience.org/library/papers/12388552PubMed
924033967Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.Chin Med J (Engl)2013https://conductscience.org/library/papers/24033967PubMed
1026361402Early detection of pancreatic cancer.Chin J Cancer Res2015https://conductscience.org/library/papers/26361402PubMed
1115051286Pancreatic cancer.Lancet2004https://conductscience.org/library/papers/15051286PubMed
1211726975Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.Nat Med2001https://conductscience.org/library/papers/11726975PubMed
1323181100CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study.Exp Ther Med2012https://conductscience.org/library/papers/23181100PubMed
1421620466Pancreatic cancer.Lancet2011https://conductscience.org/library/papers/21620466PubMed
1517089032Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease.Oncol Rep2006https://conductscience.org/library/papers/17089032PubMed
1626338423EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway.Sci Rep2015https://conductscience.org/library/papers/26338423PubMed
1722143577Surveillance of pancreatic cancer patients after surgical resection.Ann Surg Oncol2012https://conductscience.org/library/papers/22143577PubMed
1821412497Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.World J Gastroenterol2011https://conductscience.org/library/papers/21412497PubMed
1922237781Cancer statistics, 2012.CA Cancer J Clin2012https://conductscience.org/library/papers/22237781PubMed
2017923814Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2.Eur J Cancer Prev2007https://conductscience.org/library/papers/17923814PubMed

See all 31 referencesDownload CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
42811017Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives.Nat Commun2026https://conductscience.org/library/papers/42811017PubMed
42040173Pancreatic Lymphatics in Health and Disease: Evolution, Embryology, and Neural Control.Lymphatics2026https://conductscience.org/library/papers/42040173PubMed
41991735A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinoma.Sci Rep2026https://conductscience.org/library/papers/41991735PubMed
41703564Growth differentiation factor 15 promotes the malignant progression of multiple myeloma via activation of PI3K/Akt/NF-κB signaling pathway.J Transl Med2026https://conductscience.org/library/papers/41703564PubMed
41694374CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21.Front Immunol2026https://conductscience.org/library/papers/41694374PubMed
41138017Lymphatic metastasis in pancreatic cancer: from bedside to bench and back.Cancer Metastasis Rev2025https://conductscience.org/library/papers/41138017PubMed
40123816Expression of CXCR4 in the Primary Lesion of Recurrent Metastatic Breast Cancer and Its Association With Prognosis.Int J Gen Med2025https://conductscience.org/library/papers/40123816PubMed
38652207Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives.Med Oncol2024https://conductscience.org/library/papers/38652207PubMed
38540782A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.Biomolecules2024https://conductscience.org/library/papers/38540782PubMed
38253803The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients.Nat Cancer2024https://conductscience.org/library/papers/38253803PubMed
37697316The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer.World J Surg Oncol2023https://conductscience.org/library/papers/37697316PubMed
36512927Effect of tocopherol conjugation on polycation-mediated siRNA delivery to orthotopic pancreatic tumors.Biomater Adv2023https://conductscience.org/library/papers/36512927PubMed
36359736CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients.Cells2022https://conductscience.org/library/papers/36359736PubMed
36302761Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.Nat Commun2022https://conductscience.org/library/papers/36302761PubMed
36112544Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets.Clin Cancer Res2022https://conductscience.org/library/papers/36112544PubMed
36077755Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma.Cancers (Basel)2022https://conductscience.org/library/papers/36077755PubMed
35800881Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting.Stem Cells Int2022https://conductscience.org/library/papers/35800881PubMed
35269786CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives.Int J Mol Sci2022https://conductscience.org/library/papers/35269786PubMed
35188730Nanoemulsion-Assisted siRNA Delivery to Modulate the Nervous Tumor Microenvironment in the Treatment of Pancreatic Cancer.ACS Appl Mater Interfaces2022https://conductscience.org/library/papers/35188730PubMed
35119076Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer.Oncol Rep2022https://conductscience.org/library/papers/35119076PubMed

See all 36 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
CXCL126387PubTator's text mininghttps://conductscience.org/library/genes/6387NCBI Gene
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852NCBI Gene
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
VEGFC7424PubTator's text mininghttps://conductscience.org/library/genes/7424NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29434873

GET https://conductscience.org/api/papers/v1/29434873/references?page=2